预后差异和存活预测模型对于粘性与常规型子宫腺癌的子宫腺癌
Yaxin Kang1, Lele Chang1, Jing Liu2
1Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.
Cancer medicine
|May 3, 2025
概括
性腺癌 (MA) 的预后比通常类型的宫内腺癌更差. 这项研究开发了预测模型来评估MA患者的整体存活率 (OS) 和癌症特异性存活率 (CSS).
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症流行病学 癌症流行病学
- 生物统计学 生物统计学
背景情况:
- 宫内腺癌 (EA) 呈现出显著的组织学异质性.
- 通常类型的腺癌和粘膜腺癌 (MA) 是最常见的EA亚型.
研究的目的:
- 为了比较粘膜腺癌 (MA) 与通常类型腺癌的预后.
- 开发和验证MA患者的整体生存期 (OS) 和癌症特异性生存期 (CSS) 的风险预测模型.
主要方法:
- 利用SEER数据库 (2004-2021) 来获取人口和临床数据.
- 员工倾向得分匹配 (PSM) 以尽量减少混变量.
- 分析了使用卡普兰-梅尔和考克斯回归的生存数据;开发了用于风险预测的nomograms.
主要成果:
- 在MA患者中,患者的平均年龄为46岁,而在腺癌中为45岁 (p=0.021).
- 与腺癌相比,MA表现出明显较低的1年,3年和5年的OS和CSS率 (p<0.0001).
- 用于OS和CSS预测的诺姆图表是使用显著的临床变量开发和验证的.
结论:
- 粘性腺癌 (MA) 与通常类型腺癌相比,预后较差.
- 在MA中开发的OS和CSS预测模型为临床实践提供了改进的预后评估.
相关概念视频
Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
Comparing the Survival Analysis of Two or More Groups
84
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
84


